Magellan Asset Management’s Medtronic MDT Stock Holding History

Magellan Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$126M	Sell	1,454,218 -18,640	-1%	-$1.79M	1.63%	26
2025 Q4	$141M	Buy	1,472,858 +146,244	+11%	+$14.2M	1.72%	27
2025 Q3	$126M	Buy	+1,326,614	New	+$122M	1.5%	27
2022 Q4	–	Sell	-1,865	Closed	-$151K	–	125
2022 Q3	$151K	Buy	1,865 +111	+6%	+$9.97K	﹤0.01%	107
2022 Q2	$157K	Buy	1,754 +370	+27%	+$37.5K	﹤0.01%	106
2022 Q1	$154K	Sell	1,384 -828	-37%	-$87.5K	﹤0.01%	104
2021 Q4	$229K	Buy	2,212 +668	+43%	+$77.4K	﹤0.01%	101
2021 Q3	$194K	Buy	1,544 +101	+7%	+$13.1K	﹤0.01%	97
2021 Q2	$179K	Buy	1,443 +434	+43%	+$54.5K	﹤0.01%	92
2021 Q1	$119K	Buy	1,009 +399	+65%	+$46.8K	﹤0.01%	94
2020 Q4	$71K	Buy	+610	New	+$67.2K	﹤0.01%	99

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Magellan Asset Management's MDT Position: Q1 2026 in Review

Magellan Asset Management reduced its Medtronic (MDT) stake by 1.3% in Q1 2026, selling an estimated $1.79M and leaving 1,454,218 shares worth $126M. The position accounts for 1.63% of the portfolio, ranked #26.

Magellan Asset Management first reported a position in MDT in Q4 2020 and has held it in 11 quarters since. The position peaked at $141M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Magellan Asset Management held 1,454,218 shares of Medtronic worth $126M as of Q1 2026.
Magellan Asset Management sold 18,640 Medtronic shares in Q1 2026, an estimated $1.79M.
Medtronic made up 1.63% of Magellan Asset Management's portfolio in Q1 2026, its #26 holding.
Magellan Asset Management first reported a position in Medtronic in Q4 2020 and has held it in 11 quarters since.
Magellan Asset Management's Medtronic position peaked at $141M in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Magellan Asset Management's 13F filing for Q1 2026, filed 12 May 2026.